Cargando…
Cholesterol Dysmetabolism in Alzheimer’s Disease: A Starring Role for Astrocytes?
In recent decades, the impairment of cholesterol metabolism in the pathogenesis of Alzheimer’s disease (AD) has been intensively investigated, and it has been recognized to affect amyloid β (Aβ) production and clearance, tau phosphorylation, neuroinflammation and degeneration. In particular, the key...
Autores principales: | Staurenghi, Erica, Giannelli, Serena, Testa, Gabriella, Sottero, Barbara, Leonarduzzi, Gabriella, Gamba, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750262/ https://www.ncbi.nlm.nih.gov/pubmed/34943002 http://dx.doi.org/10.3390/antiox10121890 |
Ejemplares similares
-
A Crosstalk Between Brain Cholesterol Oxidation and Glucose Metabolism in Alzheimer’s Disease
por: Gamba, Paola, et al.
Publicado: (2019) -
The Controversial Role of 24-S-Hydroxycholesterol in Alzheimer’s Disease
por: Gamba, Paola, et al.
Publicado: (2021) -
ApoE3 vs. ApoE4 Astrocytes: A Detailed Analysis Provides New Insights into Differences in Cholesterol Homeostasis
por: Staurenghi, Erica, et al.
Publicado: (2022) -
24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1/PGC1α/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer’s Disease
por: Testa, Gabriella, et al.
Publicado: (2023) -
Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease
por: Gamba, Paola, et al.
Publicado: (2015)